Owner Japan Tobacco Inc.

Inventors Odani, Naoya; Hagiwara, Atsushi; Madono, Kenya; Ohe, Yasuhiro; Watanabe, Shizue; Kawai, Takashi; Ikenogami, Taku; Taniguchi, Toshio

Agent Griffith Hack

Pub. Number AU-A-2005248950

Parent 2003211617

Filing date 23 December 2005

Wipo publication date 19 January 2006

C07C 69/732 (2006.01) Esters of carboxylic acids

A61K 31/215 (2006.01)

A61K 31/216 (2006.01)

A61K 31/235 (2006.01)

A61K 31/24 (2006.01)

A61K 31/245 (2006.01)

A61K 31/277 (2006.01)

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/404 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61K 31/4453 (2006.01) - only substituted in position 1, e.g. propipocaine, diperodon

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 Drugs for disorders of the metabolism